Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Quanterix Corporation - Common Stock (NQ:QTRX)

5.438 +0.278 (+5.39%)
Streaming Delayed Price Updated: 10:27 AM EDT, Jun 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Quanterix Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Why Energizer Holdings Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Nuburu, Inc. (NYSE: BURU) shares jumped 185.6% to $1.6593 after the company announced contract with NASA to demonstrate feasibility of power beaming in space using the company’s blue laser... 
Via Benzinga
Quanterix Corp. (NASDAQ: QTRX) is a Stock Spotlight on 8/8
Via Investor Brand Network
Recap: Quanterix Q1 Earnings
Via Benzinga
Quanterix's Return On Capital Employed Insights
Via Benzinga
Preview: Quanterix's Earnings
Via Benzinga
Fox, Warner Music, Eli Lilly, Chegg And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded lower, with the Dow Jones falling around 400 points on Tuesday. Here are some big stocks recording gains in today’s session. Paymentus Holdings, Inc. (NYSE: PAY) shares rose 29.4% to... 
Via Benzinga
Quanterix Releases Operating Results for Second Quarter 2023
From Quanterix Corporation
Via Business Wire
Quanterix to Present at Canaccord Genuity 43rd Annual Growth Conference
From Quanterix Corporation
Via Business Wire
Quanterix’s Simoa® Technology Powers Large, International Reference Range Study Utilizing Serum Neurofilament Light (sNfL) to Assess Neurological Disease Activity in Pediatric Patients
From Quanterix Corporation
Via Business Wire
Quanterix to Report Second Quarter 2023 Financial Results on August 8, 2023
From Quanterix Corporation
Via Business Wire
Quanterix Launches LucentAD Biomarker Blood Test to Aid Physician Diagnosis of Alzheimer’s Disease in Patients
From Quanterix Corporation
Via Business Wire
Quanterix to Participate in Fireside Chat at Goldman Sachs Annual Global Healthcare Conference
From Quanterix Corporation
Via Business Wire
Why CohBar Shares Are Trading Lower By 161%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers 
Via Benzinga
Goldman Sachs Turns Bullish On Biotech With 'Significant Opportunity'
Shares of Quanterix Corp (NASDAQ: QTRX) spiked in early trading on Tuesday and the stock is up almost 75% year to date. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2023
Via Benzinga
Quanterix Releases Operating Results for First Quarter 2023
From Quanterix Corporation
Via Business Wire
Quanterix’s First Quarter 2023 Earnings Conference Call
From Quanterix Corporation
Via Business Wire
FDA Accelerated Approval of Tofersen Highlights Importance of Blood Neurofilament Light Chain as Surrogate Endpoint in Neurology Therapeutic Trials
From Quanterix Corporation
Via Business Wire
Quanterix to Participate in Barclays Global Healthcare Conference
From Quanterix Corporation
Via Business Wire
Quanterix Releases Operating Results for Fourth Quarter and Full Year 2022; Aligned with Expectations
From Quanterix Corporation
Via Business Wire
Quanterix to Present at Cowen’s 43rd Annual Health Care Conference
From Quanterix Corporation
Via Business Wire
Quanterix Fourth Quarter Earnings and Full Year 2022 Financial Results Conference Call
From Quanterix Corporation
Via Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Quanterix Announces Appointment of Brian Blaser to Board of Directors
From Quanterix Corporation
Via Business Wire
Quanterix Expands Laboratory Developed Test Menu with Launch of Neurofilament Light Chain Test
From Quanterix Corporation
Via Business Wire
Quanterix to Present at 41st Annual J.P. Morgan Healthcare Conference
From Quanterix Corporation
Via Business Wire
Quanterix’s Simoa® Technology Drives Advances in Alzheimer’s Disease Research Presented at 2022 Clinical Trials on Alzheimer’s Disease (CTAD) Conference
From Quanterix Corporation
Via Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Quanterix to Participate in the 15th Clinical Trials on Alzheimer’s Disease (CTAD) Task Force
From Quanterix Corporation
Via Business Wire
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday
Gainers 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS